awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30675199-77E6F5AD-9A4C-4A3C-B7AC-83402182E95A
Q30675199-77E6F5AD-9A4C-4A3C-B7AC-83402182E95A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30675199-77E6F5AD-9A4C-4A3C-B7AC-83402182E95A
Is extrapolation of the safety and efficacy data in one indication to another appropriate for biosimilars?
P2860
Q30675199-77E6F5AD-9A4C-4A3C-B7AC-83402182E95A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30675199-77E6F5AD-9A4C-4A3C-B7AC-83402182E95A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62c3e7cce2747178dc9ca5afc5384632f7b75b3f
P2860
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.